These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37796044)

  • 1. Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
    Wu WJ; Lin CL; Liu CJ; Huang YW; Hu JT; Yu MW
    J Med Virol; 2023 Oct; 95(10):e29138. PubMed ID: 37796044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.
    Liu J; Yang HI; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Chen CJ
    Hepatology; 2016 Aug; 64(2):381-9. PubMed ID: 27079545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
    Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
    J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
    Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
    Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
    Yoo S; Kim JY; Lim YS; Han S; Choi J
    J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
    Su TH; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen CL; Chen PJ; Kao JH; Chen DS
    PLoS One; 2013; 8(2):e55916. PubMed ID: 23437072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
    Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
    Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
    Ahn JM; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    PLoS One; 2015; 10(12):e0144777. PubMed ID: 26696302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B inactive carriers: clinical course and outcomes.
    Tong MJ; Trieu J
    J Dig Dis; 2013 Jun; 14(6):311-7. PubMed ID: 23433008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
    Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
    World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.
    Brouwer WP; Chan HL; Brunetto MR; Martinot-Peignoux M; Arends P; Cornberg M; Cherubini B; Thompson AJ; Liaw YF; Marcellin P; Janssen HL; Hansen BE;
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1481-1489.e5. PubMed ID: 26872398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
    Park YM; Lee SG
    World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection.
    Sun F; Li Z; Hu L; Deng W; Jiang T; Wang S; Bi X; Lu H; Yang L; Lin Y; Zeng Z; Shen G; Liu R; Chang M; Wu S; Gao Y; Hao H; Xu M; Chen X; Zhang L; Lu Y; Dong J; Xie Y; Li M
    Front Immunol; 2022; 13():1082091. PubMed ID: 36505492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection.
    Minuk GY; Macrury S; Uhanova J; Caouette S; Coleman N; Cummings K; Larke B; Vardy L; Triet Huyn C; Osiowy C
    J Viral Hepat; 2013 Dec; 20(12):890-6. PubMed ID: 24304459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.